http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2132334-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1993-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86edf9061cb24836f2436666986168ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc77a55da489f39ef3f0d48a9f9433bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633cb1026b4d4587faf0057b735e4078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4ec8df0fcd2ba1be8255e67ec79ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e947f135c682c6fac1a1077d434add
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78bcf6f45d031898c4c116a7bb6a4c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2309dac897470180befec6f748e1aee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6beb45e005d6809b6d4f1b9fcb6d901
publicationDate 1999-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2132334-C1
titleOfInvention Dolostatine analog
abstract FIELD: organic chemistry, peptides. SUBSTANCE: invention relates to peptides of the general formula (I) where R 1 is C 1-7 -alkyl; R 2 is C 1-4 -alkyl; X is C 1-5 -alkyl; R 3 is a lower alkyl; B - is C 1-5 -alkyl; D is C 1-5 -alkoxy; M - phenylalanine; R 4 - H; R 5 - H or benzyl; d = 0 or 1, or their salts showing the improved therapeutic properties for treatment of patients with neoplasms as compared with dolostatine-10. Proposed analog can be synthesized by conventional methods unlike to the latter. EFFECT: improved therapeutic properties. 2 cl, 2 tbl, 2 ex
priorityDate 1992-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410550970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410441334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457193433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID120269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420243235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14584527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426688350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19927359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448748630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453739895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9810929
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID161756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449982031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448108619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424593126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21663959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18476134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448345200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID199401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508222
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID161756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11953719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13586794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33645

Total number of triples: 84.